While previous studies have established the importance of SIRT3 activation in DN management, our study provides the first demonstration that HKL’s nephroprotective effects are specifically mediated through SIRT3-dependent suppression of NLRP3 inflammasome signalling and GSDMD-mediated pyroptosis. The gene discussed is SIRT3; the disease is liver dysplastic nodule.